Posted by Michael Wonder on 18 May 2022
VenoStent technology receives breakthrough device designation by FDA
17 May 2022 - Designation to promote more rapid agency and market access for VenoStent.
VenoStent announces that the Center for Devices and Radiological Health at the FDA has granted its novel technology, the SelfWrap bioabsorbable perivascular wrap, breakthrough device designation.
